S 111 (Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg)
Generic Name: hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
Pill with imprint S 111 is Purple, Capsule-shape and has been identified as Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg. It is supplied by Mission Pharmacal Company.
Uribel is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Uribel hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for S 111


Uribel
- Generic Name
- hyoscyamine/methenamine/methylene blue/phenyl salicylate/sodium biphosphate
- Imprint
- S 111
- Strength
- hyoscyamine 0.12 mg / methenamine 118 mg/methylene blue 10 mg / phenyl salicylate 36 mg / sodium phosphate 40.8 mg
- Color
- Purple
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Urinary antispasmodics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mission Pharmacal Company
- National Drug Code (NDC)
- 00076-0111 (Discontinued)
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
gelatin,
magnesium stearate,
propylene glycol,
shellac,
silicon dioxide
Note: Inactive ingredients may vary.
Related images for "S 111"
More about Uribel (hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium biphosphate)
- Side effects
- Drug interactions
- Dosage information
- Reviews (35)
- Drug images
- En español
- Drug class: urinary antispasmodics
Patient resources
- Other brands
- Uro-MP, Uretron DS, Ustell, Phosphasal, ... +16 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.